The country has received 1,200 doses of a candidate Sudan Ebola vaccine from the WHO.
The latest case is the stillborn baby of a mother who survived Ebola.
The infection lifts the country's total to 141 lab-confirmed cases, 55 of them fatal.
District officials in the latest affected area of Uganda reported two more Ebola cases that involve family members of a recently confirmed case-patient in Jinja, according to the Monitor, a Kampala-based newspaper, reported today.
Uganda has reported one more lab-confirmed Ebola infection, which involves a 23-year-old woman who is a healthcare worker in Mubende, one of the outbreak's hot spots, according to an update yesterday from the World Health Organization (WHO) Uganda office.
The report reveals encouraging investments but also persistent COVID-19 vaccine inequity and a nearly vacant pipeline for products to treat or prevent emerging pathogens that have pandemic potential.
Uganda's health ministry yesterday reported that Ebola has spread to Jinja district in the southeastern part of the country (see Google Maps image below).
At a World Health Organization (WHO) briefing today, Director-General Tedros Adhanom Ghebreyesus, PhD, said Uganda's government is making progress in its battle against Ebola, but he raised concerns about case detections outside the main hot spots.
A study of US patients aged 0 to 20 years hospitalized for COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in 2020 and 2021 shows that 22% had a neurologic condition, including 9% with life-threatening illness.
In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
